NEW YORK, Sept. 13, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Valneva SE (“Valneva” or the “Company”) (NASDAQ: VALN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, […]
NEW YORK, Sept. 13, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Valneva SE (“Valneva” or the “Company”) (NASDAQ: VALN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, […]
NEW YORK, Sept. 13, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Anika Therapeutics, Inc. (“Anika” or the “Company”) (NASDAQ: ANIK). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The […]
NEW YORK, Sept. 13, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Anika Therapeutics, Inc. (“Anika” or the “Company”) (NASDAQ: ANIK). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The […]
NEW YORK, March 3, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Perpetua Resources Corp (“Perpetua” or the “Company”) (NASDAQ: PPTA). Such investors are advised to contact Danielle Peyton at [email protected] or […]
